| 2022-08-29 |
股东大会：
将于2022-10-04召开股东大会
会议内容 ▼▲
- 1.To elect Scott R. Milford, Bruce T. Bernstein, Robert Weinstein, Donald E. Stout and Michael Lebowitz to our Board of Directors;
2.To ratify the selection of Friedman LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.To approve a proposed amendment to the XpresSpa Group, Inc. Amended and Restated Certificate of Incorporation to effect a reverse stock split of our issued and outstanding shares of common stock, at a ratio of between 1-for-2 and 1-for-6;
4.To approve a proposed amendment to our 2020 Equity Incentive Plan (the “Plan”) to increase the number of shares authorized for issuance under the Plan by 7,500,000 shares;
5.To approve, by an advisory vote, the compensation of our named executive officers, as disclosed in the proxy statement;
6.To approve an adjournment of our annual meeting of stockholders to solicit additional proxies if there are not sufficient votes in favor of proposals 2 through 5.
|
| 2022-08-15 |
详情>>
股本变动：
变动后总股本9427.81万股
|
| 2022-08-15 |
详情>>
业绩披露：
2022年中报每股收益-0.12美元,归母净利润-1220.1万美元,同比去年增长-120.91%
|
| 2022-08-15 |
财报披露：
美东时间 2022-08-15 盘后发布财报
|
| 2022-05-16 |
详情>>
业绩披露：
2022年一季报每股收益-0.04美元,归母净利润-428.3万美元,同比去年增长-305.59%
|
| 2022-03-31 |
详情>>
业绩披露：
2021年年报每股收益0.03美元,归母净利润334.90万美元,同比去年增长103.70%
|
| 2021-11-15 |
详情>>
业绩披露：
2021年三季报(累计)每股收益0.00美元,归母净利润7.40万美元,同比去年增长100.10%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-20 |
股东大会：
将于2021-09-30召开股东大会
会议内容 ▼▲
- 1.To elect Douglas Satzman, Bruce T. Bernstein, Robert Weinstein, Donald E. Stout and Michael Lebowitz to our Board of Directors;
2.To ratify the selection of Friedman LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021;
3.To approve a proposed amendment to the XpresSpa Group, Inc. Amended and Restated Certificate of Incorporation to increase the number of authorized shares of our common stock by 100,000,000, from 150,000,000 to 250,000,000;
4.To approve, by an advisory vote, the compensation of our named executive officers, as disclosed in the accompanying proxy statement;
5.To approve an adjournment of our annual meeting of stockholders, if necessary, to solicit additional proxies if there are not sufficient votes in favor of proposals 2 through 4.
|
| 2021-08-16 |
详情>>
业绩披露：
2021年中报每股收益-0.05美元,归母净利润-552.3万美元,同比去年增长91.96%
|
| 2021-05-17 |
详情>>
业绩披露：
2021年一季报每股收益-0.01美元,归母净利润-105.6万美元,同比去年增长90.05%
|
| 2021-03-31 |
详情>>
业绩披露：
2020年年报每股收益-2.05美元,归母净利润-9048.8万美元,同比去年增长-326.37%
|
| 2020-11-16 |
详情>>
业绩披露：
2020年三季报(累计)每股收益-2.15美元,归母净利润-7480.5万美元,同比去年增长-428.47%
|
| 2020-09-18 |
股东大会：
将于2020-10-28召开股东大会
会议内容 ▼▲
- 1.To elect Douglas Satzman, Bruce T. Bernstein, Robert Weinstein, Donald E. Stout and Michael Lebowitz to our Board of Directors;
2.To ratify the selection of Friedman LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020;
3.To approve the XpresSpa Group, Inc. 2020 Equity Incentive Plan (the “2020 Plan”);
4.To approve, by an advisory vote, the compensation of our named executive officers, as disclosed in this proxy statement;
5.To approve an adjournment of our annual meeting of stockholders, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the proposals referred to in clauses (2) through (4).
|
| 2020-08-19 |
详情>>
业绩披露：
2020年中报每股收益-3.09美元,归母净利润-6869.4万美元,同比去年增长-637.77%
|
| 2020-07-06 |
详情>>
业绩披露：
2020年一季报每股收益-1.74美元,归母净利润-1061.6万美元,同比去年增长-257.08%
|
| 2020-05-22 |
复牌提示：
2020-05-22 09:34:53 停牌，复牌日期 2020-05-22 09:39:53
|
| 2020-05-07 |
股东大会：
将于2020-05-28召开股东大会
会议内容 ▼▲
- 1.To authorize, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of our Common Stock in connection with certain warrant exchange agreements entered into in March 2020;
2.To authorize, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of our Common Stock pursuant to that certain Fourth Amended and Restated Convertible Promissory Note, dated March 6, 2020, by and between the Company and B3D, LLC;
3.To approve a proposed amendment to the Certificate of Designation, Preferences, Rights and Limitations of our Series E Convertible Preferred Stock to provide for the voluntary adjustment of the conversion price by our Board of Directors in its discretion, and to authorize, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of our Common Stock upon the conversion of our Series E Convertible Preferred Stock;
4.To approve a proposed amendment to the XpresSpa Group, Inc. Amended and Restated Certificate of Incorporation to effect a reverse stock split of our issued and outstanding shares of Common Stock, at a ratio of between 1-for-2 and 1-for-25;
5.To approve an adjournment of our special meeting of stockholders, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the proposals referred to in proposals (1) through (4).
|
| 2019-08-12 |
股东大会：
将于2019-09-09召开股东大会
会议内容 ▼▲
- 1.To elect Douglas Satzman, Bruce T. Bernstein, Donald E. Stout and Salvatore Giardina to our Board of Directors;
2.To ratify the selection of CohnReznick LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019;
3.To authorize, for purposes of complying with Nasdaq Listing Rules 5635(a), 5635(b) and 5635(d), the issuance of shares of our Common Stock underlying the instruments below (including upon the operation of anti-dilution provisions, voluntary adjustment provisions and/or the reduction of conversion ratios):the Series F Convertible Preferred Stock issued by us pursuant to that certain Amendment to Securities Purchase Agreement and Class A Warrants and Class B Warrants, dated as of July 8, 2019 (the “May 2018 SPA Amendment”);the amendment to the Class A Warrants pursuant to the May 2018 SPA Amendment;notes, warrants and Series E Convertible Preferred Stock issued by us pursuant to that certain Securities Purchase Agreement, dated as of July 8, 2019, by and between us and Calm.com, Inc. (the “Calm Purchase Agreement”);the convertible note issued by us pursuant to that certain Fourth Amendment to Credit Agreement, dated as of July 8, 2019, by and between XpresSpa Holdings, LLC and B3D, LLC (the “B3D Credit Agreement Amendment”);warrants issued by us pursuant to that certain amendment to certain outstanding warrants issued in December 2016 to holders of our Series D Convertible Preferred Stock (the “December 2016 Warrant Amendment”);the Series D Convertible Preferred Stock issued by us pursuant to that certain certificate of amendment to the Certificate of Designation of Series D Convertible Preferred Stock (the “Series D COD Amendment”);
4.To approve a proposed amendment to the XpresSpa Group, Inc. Amended and Restated Certificate of Incorporation to increase the number of authorized shares of our preferred stock by 5,000,000, from 5,000,000 to 10,000,000;
5.To approve a proposed amendment to our 2012 Employee, Director and Consultant Equity Incentive Plan, as amended (the “Plan”), to increase the number of shares authorized for issuance under the Plan by 2,165,000 shares;
6.To approve a proposed amendment to the XpresSpa Group, Inc. Amended and Restated Certificate of Incorporation to effect a reverse stock split of our issued and outstanding shares of Common Stock, at a ratio of between 1-for-2 and 1-for-25;
7.To approve, by an advisory vote, the compensation of our named executive officers, as disclosed in this proxy statement;
8.To approve by an advisory vote the frequency of holding an advisory vote on compensation of our named executive officers;
9.To approve an adjournment of our annual meeting of stockholders, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the proposals referred to in proposals (2) through (7).
|
| 2019-02-25 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2018-08-08 |
股东大会：
将于2018-09-18召开股东大会
会议内容 ▼▲
- 1.To elect Edward Jankowski, Bruce T. Bernstein, Donald E. Stout, Salvatore Giardina and Richard K. Abbe to our Board of Directors;
2.To ratify the selection of CohnReznick LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018;
3.To authorize, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock underlying convertible notes and warrants issued by us pursuant to the terms of that certain Securities Purchase Agreement, dated May 15, 2018, by and among XpresSpa Group, Inc. and the investors named therein, in an amount equal to or in excess of 20% of our common stock outstanding before the issuance of such convertible notes and warrants (including upon the operation of “full-ratchet” anti-dilution provisions contained in such convertible notes and warrants);
4.To approve an amendment to the XpresSpa Group, Inc. Amended and Restated Certificate of Incorporation to effect a reverse stock split of our issued and outstanding shares of common stock, at a ratio of between 5-for-1 and 25-for-1;
5.To approve, by an advisory vote, the compensation of our named executive officers, as disclosed in this proxy statement,
6.To approve an adjournment of our annual meeting of stockholders, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the proposals referred to in clauses (2) through (5).
|
| 2017-09-25 |
股东大会：
将于2017-11-08召开股东大会
会议内容 ▼▲
- 1. To elect Andrew D. Perlman, John Engelman, Donald E. Stout, Salvatore Giardina, Bruce T. Bernstein and Richard K. Abbe to our Board of Directors, each to serve a one-year term expiring in 2018 or until such director’s successor is elected and qualified or until such director’s earlier death, resignation or removal;
2. To ratify the selection of CohnReznick LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017;
3. To approve, by an advisory vote, the compensation of our named executive officers, as disclosed in this proxy statement;
4. To approve an adjournment of our annual meeting of stockholders, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the proposals referred to in clauses (2) and (3);
5. To transact such other business that is properly presented at the annual meeting and any adjournments or postponements thereof.
|
| 2015-12-09 |
详情>>
内部人交易：
Weinstein Cliff股份增加5000.00股
|
| 2015-11-25 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2015-09-25 |
股东大会：
将于2015-11-16召开股东大会
会议内容 ▼▲
- 1.To elect six (6) directors, each to serve a one-year term expiring in 2016 or until such director’s successor is elected and qualified or until such director’s earlier death, resignation or removal;
2.To approve a proposed amendment to our amended and restated certificate of incorporation to effect a reverse stock split of our issued and outstanding shares common stock, at a ratio within the range of one-for-two to one-for-ten, such ratio to be determined by our Board of Directors;
3.To authorize, for purposes of complying with NASDAQ Listing Rule 5635(d), the issuance of shares of our common stock underlying convertible notes and warrants issued by us pursuant to the terms of that certain Securities Purchase Agreement, dated May 4, 2015, by and among Vringo, Inc. and the investors named therein, in an amount equal to or in excess of 20% of our common stock outstanding before the issuance of such convertible notes and warrants;
4.To approve a proposed amendment to our amended and restated certificate of incorporation to increase the number of our authorized shares of common stock by 100,000,000, from 150,000,000 to 250,000,000 shares;
5.To approve a proposed amendment to Vringo, Inc. 2012 Employee, Director and Consultant Equity Incentive Plan, or the Plan, to increase the number of shares of common stock reserved for issuance under the Plan to up to a maximum of 21,000,000 shares (on a pre-split basis);
6.To ratify the selection of CohnReznik LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2015;
7.To approve, by an advisory vote, the compensation of our named executive officers, as disclosed in this proxy statement;
8.To approve an adjournment of our annual meeting of stockholders, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the proposals referred to in clauses (2) through (5);
9.To transact such other business that is properly presented at the annual meeting and any adjournments or postponements thereof.
|
| 2014-04-29 |
股东大会：
将于2014-06-11召开股东大会
会议内容 ▼▲
- 1. To elect eight (8) directors to serve one-year terms expiring in 2015 or until such director’s successor is elected and qualified or until such director’s earlier death, resignation or removal;
2. To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2014;
3. To approve by an advisory vote the compensation of our named executive officers, as disclosed in this proxy statement;
4. To transact such other business that is properly presented at the annual meeting and any adjournments or postponements thereof.
|
| 2013-06-06 |
股东大会：
将于2013-07-18召开股东大会
会议内容 ▼▲
- 1. To elect eight (8) directors to serve one-year terms expiring in 2014 or until such director’s successor is elected and qualified or until such director’s earlier death, resignation or removal;
2. To ratify the appointment of Somekh Chaikin, a member firm of KPMG International, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2013;
3. To approve by an advisory vote the compensation of our named executive officers, as disclosed in this proxy statement;
4. To approve by an advisory vote the frequency of holding an advisory vote on compensation of our named executive officers;
5. To transact such other business that is properly presented at the annual meeting and any adjournments or postponements thereof.
|